Why the study?
Patients with recurrent mitral regurgitation after surgical repair are treated with re-repair or valve replacement, but comparative outcomes between these approaches needed evaluation.
Does mitral valve re-repair compared to replacement improve survival or reduce recurrent mitral regurgitation in patients with recurrent MR after previous surgical repair?
Does mitral valve re-repair compared to replacement improve survival or reduce recurrent mitral regurgitation in patients with recurrent MR after previous surgical repair?
While mitral valve re-repair is associated with a high rate of recurrent significant MR at 8 years, it may offer a survival advantage over valve replacement, suggesting a highly selective approach is needed.
May warrant selective re-repair despite recurrent MR; leaves open whether survival trend is causal or selection-driven.
OBJECTIVES: Patients with recurrent mitral regurgitation after surgical repair are currently treated with a re-repair procedure or valve replacement. The aim of this study was to compare outcomes of our series of patients who underwent re-repair versus replacement in this setting. METHODS: From 2003 to 2017, a total of 79 patients with recurrent mitral regurgitation underwent re-repair, group A (39), or replacement, group B (40). Mean follow-up was 7.4 ± 3.27 years (max 14.4). Inverse Probability of Treatment Weighting was used to create comparable distributions of the covariates; the Kaplan-Meier method was used for survival and competing risk analysis for time to cardiac death, time to recurrence of MR ≥3+ and MR ≥2+. RESULTS: A re-repair was possible in 49.4% of patients (39/79). At hospital discharge, residual MR ≥2+ was present in 5 patients in group A, and none in group B (P < 0.001). The paired overall survival at 8 years was 100% in the re-repair group and 96.5 ± 2.34% in the replacement group (P = 0.069). The cumulative incidence function of cardiac death, with non-cardiac death as competitive event, at 8 years was 0% in group A and 3.5 ± 2.34% in group B (P = 0.077). The cumulative incidence function of MR ≥3+ at 8 years was 29.2 ± 8.81% in group A and 0% in group B (P < 0.001). CONCLUSIONS: Recurrent significant mitral regurgitation after re-repair is not rare already at 8 years, but the survival tends to be worse after replacement. This finding calls for a very selective approach in pursuing a re-repair only when the intraoperative findings and the immediate results are very reassuring as far as long-term durability is concerned.
No takes yet. Share an insight, caveat, or question.
Trumello et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: